Drug profile · INN
lamivudine
3TC
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lamivudine (3TC) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN lamivudine
Brand 3TC
Route ORAL
Formulation SOLUTION
ATC code J05AF05
Originator ViiV Healthcare Pty Ltd
Frequently asked questions
What is lamivudine?
lamivudine (3TC) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lamivudine?
3TC is a marketed brand name for lamivudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lamivudine?
lamivudine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.